Panagora Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-29,676
| Closed | -$121K | – | 1525 |
|
|
2023
Q1 | $121K | Sell |
29,676
-126,246
| -81% | -$515K | ﹤0.01% | 1411 |
|
|
2022
Q4 | $783K | Buy |
155,922
+11,778
| +8% | +$59.1K | 0.01% | 984 |
|
|
2022
Q3 | $1.89M | Buy |
144,144
+48,639
| +51% | +$636K | 0.01% | 613 |
|
|
2022
Q2 | $1.22M | Buy |
95,505
+22,689
| +31% | +$291K | 0.01% | 809 |
|
|
2022
Q1 | $1.11M | Buy |
72,816
+5,750
| +9% | +$87.7K | 0.01% | 885 |
|
|
2021
Q4 | $1.19M | Buy |
+67,066
| New | +$1.19M | 0.01% | 839 |
|